DFA alleges that the agencies violated the Administrative Procedure Act and the Paperwork Reduction Act by removing public access to the webpages without giving adequate notice in advance. The CDC, ...
Jack & The Green Sprouts, a Wisconsin-based manufacturer, issued a voluntary recall for expired alfalfa sold at grocery stores in three states.
A federal judge ordered health agencies Tuesday to reinstate certain webpages taken down in response to President Donald ...
The raw pet food industry has grown rapidly despite recalls and health warnings, according to USA TODAY reporting ... Under the Food and Drug Administration’s update Friday, officials said ...
With that pretext, it gives the U.S. a broader and more aggressive repertoire of tools for confronting drug cartels that send drugs into the country. “A terrorist designation would expand the ...
The Food and Drug Administration announced it would decide by April 2024 whether chemical hair straightening products sold in the U.S. would be banned from using formaldehyde or ingredients that ...
The CDC, FDA, HHS and NIH have all been told to pause external communications, including publishing scientific reports, updating websites or issuing health advisories. The directive came without ...
Languages: English and Urdu Depression rates have reached record highs across the U.S. A Gallup poll from 2023 ... which is made from the drug esketamine, had been approved in 2019 for patients ...
The Food and Drug Administration (FDA) approved Johnson & Johnson’s ketamine-derived nasal spray to help millions of U.S. patients suffering from severe depression. Spravato, approved as a ...
The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression ...
Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...
They acknowledge the need for more testing to confirm drug safety and efficacy, but they suggest if these results translate to human patients, ErSO-TFPy could be transformative for ER+ breast ...